Clariant Expands Pharmaceutical Excipients, Specialty Chemicals Facilities in China

Business Expansion Clariant Expands Pharmaceutical Excipients, Specialty Chemicals Facilities in China

2025-11-07 Source: Press release Clariant 3 min Reading Time

Related Vendors

Clariant SE (Deutschland) GmbH

Glatt Ingenieurtechnik GmbH

Italvacuum, Srl

Frewitt fabrique de machines SA

With an aim to strengthen its position in China, Clariant has recently expanded its pharmaceutical excipients and specialty chemicals facilities at Daya Bay in China.

Shanghai/China – Marking a significant milestone in its Asian growth strategy, Clariant has unveiled its newly expanded state-of-the-art facilities at Daya Bay, China, following the completion of its strategic CHF 80-million investment, substantially boosting Clariant's manufacturing capabilities in one of its key growth markets.

The strategic expansion significantly enhances Clariant's manufacturing capabilities in two key areas: pharmaceutical excipients and specialty chemicals for personal and home care applications. This dual focus reflects Clariant's commitment to meeting growing demand in the Chinese market while strengthening its position as a leading supplier of high-quality specialty chemicals in Asia.

"This investment represents a pivotal moment for Clariant's operations in China," said Christian Vang, Business President Care Chemicals at Clariant. "With these expanded facilities, we are now better positioned to contribute to the health and wellbeing of Chinese consumers while supporting the growth of local industries with our innovative specialty chemicals."

The pharmaceutical capabilities expansion includes a second spray tower specifically designed to serve customers in south China. This enhancement has positioned Clariant as a key supplier for both Active Pharmaceutical Ingredients (APIs) in laxatives and pharmaceutical excipients throughout China. The Daya Bay facility now serves Clariant's healthcare business, maintaining consistent quality standards across China and worldwide.

With over 30 years of experience as a recognized manufacturer of polyethylene glycols (PEGs), Clariant has significantly expanded its Polyglykol capacity at the Daya Bay site. The healthcare product portfolio includes essential ingredients such as Vitipure, Polyglykol, Lanogen, and Motusflex, which function as solubilizers, emulsifiers, and solvents in pharmaceutical formulations. Additionally, the Polyglykol brand encompasses APIs used in laxative formulations and ophthalmic medicines.

Stay up to Date

Do you want the latest news, specialist articles and information on new products? Then you can register for our free newsletter:

Choose your Newsletter

Complementing the pharmaceutical expansion, Clariant has also expanded their multi-purpose plant (MPP) at Daya Bay with an additional reactor. This facility is dedicated to producing specialty chemicals, including mild surfactants for the beauty industry and soil release polymers for the home care sector under the Texcare range. These products cater to the growing consumer demand for gentle yet effective personal care products and high-performance home care solutions.

Clariant's Daya Bay expansion features high-performance surfactants, including water-based coatings formulations that reduce VOC emissions and synthetic lubricant ingredients that extend equipment life. In addition, the company offers efficient crop protection additives for precision agriculture and soil health series enhancers that improve water and nutrient retention. These are only a few examples of the company’s commitment to sustainable chemistry solutions addressing China's evolving industrial needs and which deliver solutions balancing efficiency, safety, and sustainability for China's market.

The expansion has also significantly increased Clariant's production capacity for Ethylene Oxide Derivatives (EODs) and a broader chemical portfolio at Daya Bay.

"The evolution of Daya Bay from Clariant's first ethoxylation plant in Asia to an integrated Multi-Purpose Plant and Ethylene Oxide Derivatives site demonstrates our long-term vision for the region," explains Christian Vang. "By bringing our innovation and expertise closer to customers, we're better positioned to help drive their developments forward while addressing our customers sustainability targets and end-product performance needs."

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Date: 08.12.2025

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

"This expansion not only increases our production capacity but also enhances our ability to collaborate closely with local customers on tailored solutions," added Vang. "We're now better equipped than ever to support the innovation needs of our Chinese customers across the pharmaceutical, personal care, and home care sectors."

The newly opened facilities at Daya Bay will play a crucial role in Clariant's growth strategy in Asia, particularly in China's rapidly evolving specialty chemicals market.

(ID:50620080)